Aflatoxins as a risk factor for liver cirrhosis: a systematic review and meta-analysis

被引:19
|
作者
Mekuria, Abraham Nigussie [1 ]
Routledge, Michael N. [2 ,3 ]
Gong, Yun Yun [4 ]
Sisay, Mekonnen [5 ]
机构
[1] Haramaya Univ, Sch Pharm, Dept Pharmacol, POB 235, Harare, Zimbabwe
[2] Univ Leeds, Sch Med, Leeds, England
[3] Jiangsu Univ, Sch Food & Biol Engn, Zhenjiang, Jiangsu, Peoples R China
[4] Univ Leeds, Sch Food Sci & Nutr, Leeds, W Yorkshire, England
[5] Haramaya Univ, Sch Pharm, Dept Pharmacol, Harar, Ethiopia
来源
BMC PHARMACOLOGY & TOXICOLOGY | 2020年 / 21卷 / 01期
关键词
Aflatoxin; mycotoxin; Liver cirrhosis; Chronic liver disease; Meta-analysis; HEPATOCELLULAR-CARCINOMA; NONALCOHOLIC STEATOHEPATITIS; HEPATITIS; DAMAGE; INFECTION; APOPTOSIS; EXPOSURE; CURCUMIN; MUTATION; PATHWAY;
D O I
10.1186/s40360-020-00420-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background Liver cirrhosis is characterized by fibrosis and nodule formation in the liver, due to a chronic injury, and subsequent alteration of the normal architecture of the liver. Even though there is a huge effort to elucidate the possible etiologic factors of liver cirrhosis, a significant number of cases are cryptogenic, especially in Sub Saharan Africa, where there is a high burden of aflatoxin exposure. Aflatoxins are known to cause hepatocellular carcinoma, which share similar etiologic factors with liver cirrhosis. This study aimed to assess the association between aflatoxin exposure and the risk of liver cirrhosis. Methods Relevant studies were identified through systematic searches conducted in Ovid MEDLINE, PubMed and Google Scholar. Also, by searching the references of retrieved articles. The abstracts and full text were screened for eligibility and the risk of bias was assessed for each study using Joanna Briggs Institute (JBI) critical appraisal checklist for observational studies. The extracted data from included studies using Microsoft Excel were exported to Stata software version 15.0 for analyses. The overall pooled estimation of outcomes was calculated using a random-effects model of DerSimonian-Laird method at a 95% confidence level. The heterogeneity of studies was determined using I2 statistics. The presence of publication bias between studies was evaluated using the Begg's and Egger's tests and funnel plot. The protocol of this systematic review and meta-analysis was registered in the Prospero database with reference number ID: CRD42019148481. Results A total of 5 studies published between the years 2005 and 2018 that met the pre-defined inclusion and exclusion criteria were included. The meta-analysis showed that a significant increase in the risk of liver cirrhosis is associated with aflatoxin exposure (unadjusted pooled odds ratio (OR) = 3.35, 95% CI: 2.74-4.10, p = 0.000; I-2 = 88.3%, p = 0.000; adjusted OR = 2.5, 95% CI: 1.84-3.39, p = 0.000; I-2 = 0%, p = 0.429). Conclusions The present meta-analysis suggests that aflatoxin exposure is associated with a higher risk of liver cirrhosis.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Aflatoxins as a risk factor for liver cirrhosis: a systematic review and meta-analysis
    Abraham Nigussie Mekuria
    Michael N. Routledge
    Yun Yun Gong
    Mekonnen Sisay
    [J]. BMC Pharmacology and Toxicology, 21
  • [2] Alcohol as a risk factor for liver cirrhosis: A systematic review and meta-analysis
    Rehm, Juergen
    Taylor, Benjamin
    Mohapatra, Satya
    Irving, Hyacinth
    Baliunas, Dolly
    Patra, Jayadeep
    Roerecke, Michael
    [J]. DRUG AND ALCOHOL REVIEW, 2010, 29 (04) : 437 - 445
  • [3] Risk of Stroke in Liver Cirrhosis: A Systematic Review and Meta-Analysis
    Zheng, Kexin
    Yoshida, Eric M.
    Tacke, Frank
    Li, Yingying
    Guo, Xiaozhong
    Qi, Xingshun
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2020, 54 (01) : 96 - 105
  • [4] Alcohol Consumption and Risk of Liver Cirrhosis: A Systematic Review and Meta-Analysis
    Roerecke, Michael
    Vafaei, Afshin
    Hasan, Omer S. M.
    Chrystoja, Bethany R.
    Cruz, Marcus
    Lee, Roy
    Neuman, Manuela G.
    Rehm, Jurgen
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 (10): : 1574 - 1586
  • [5] The association between liver cirrhosis and fracture risk: A systematic review and meta-analysis
    Liang, Jie
    Meng, Wei-Dong
    Yang, Jun-Ming
    Li, Sheng-Long
    Zhong, Mi-Na
    Hou, Xuan-Xuan
    Wang, Ran
    Long, Yu-Ying
    Bao, Liang-Xiao
    Bao, Ming
    [J]. CLINICAL ENDOCRINOLOGY, 2018, 89 (04) : 408 - 413
  • [6] Cirrhosis and risk of stroke: A systematic review and meta-analysis
    Xiong, Jianping
    Xu, Weiyu
    Huang, Hanchun
    Bian, Jin
    Wang, Anqiang
    Bai, Yi
    Lin, Jianzhen
    Xu, Yiyao
    Lu, Xin
    Zhao, Haitao
    [J]. ATHEROSCLEROSIS, 2018, 275 : 296 - 303
  • [7] Prevalence of Sarcopenia in Liver Cirrhosis: A Systematic Review and Meta-Analysis
    Mazeaud, Simon
    Zupo, Roberta
    Couret, Alexis
    Panza, Francesco
    Sardone, Rodolfo
    Castellana, Fabio
    [J]. CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2023, 14 (07)
  • [8] Prevalence of diabetes in liver cirrhosis: A systematic review and meta-analysis
    Lee, Wai Gin
    Wells, Cameron I.
    McCall, John L.
    Murphy, Rinki
    Plank, Lindsay D.
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2019, 35 (06)
  • [9] Midodrine in Liver Cirrhosis With Ascites: A Systematic Review and Meta-Analysis
    Shrestha, Dhan B.
    Budhathoki, Pravash
    Sedhai, Yub Raj
    Baniya, Ram Kaji
    Karki, Pearlbiga
    Jha, Pinky
    Mainali, Gaurab
    Acharya, Roshan
    Sodhi, Amik
    Kadaria, Dipen
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (07)
  • [10] Systematic review with meta-analysis: coffee consumption and the risk of cirrhosis
    Kennedy, O. J.
    Roderick, P.
    Buchanan, R.
    Fallowfield, J. A.
    Hayes, P. C.
    Parkes, J.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (05) : 562 - 574